Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: Cancer Lett. 2015 Dec 3;373(1):88–96. doi: 10.1016/j.canlet.2015.11.029

Fig. 5.

Fig. 5

Flow cytometry analysis of tumor-infiltrating immune cells. Flow cytometry of tumors excised on treatment day 12 (Fig. 2) were analyzed for increases in the indicated tumor-infiltrating immune cells by flow cytometry using the indicated immune cell markers. Data comparing untreated and CPA-treated tumors are shown in Appendix S1, and representative flow cytometry gating images are shown in Appendix S1. Significance for comparisons to untreated tumors is indicated by: *p < 0.05; **p < 0.01; ***p < 0.001; and ****p < 0.0001. Combination treatment groups were compared to CpG-1826 alone (dagger symbol) or CPA (double dagger) by two-tailed t-test, p < 0.05.